Sequencing Consumables Market Size & Share 2024 – 2032

Sequencing Consumables Market Size

Sequencing Consumables Market was valued at around USD 7 billion in 2023 and is estimated to register a CAGR of over 22.5% between 2024 and 2032. Sequencing consumables refer to the various materials and reagents used in the process of DNA sequencing. It encompasses a wide range of products and supplies that are essential for conducting sequencing experiments and analyses.

Moreover, NGS represents a paradigm shift in the field of genomics, offering unprecedented speed, accuracy, and scalability compared to traditional sequencing methods. As NGS platforms have become more widely adopted across diverse applications such as research, diagnostics, and clinical genomics, the demand for consumables tailored to these high-throughput sequencing systems has grown considerably. The next generation sequencing (NGS) technologies which is estimated to grow at 19% CAGR during the forecast period, has significantly influenced and shaped the sequencing consumables market.
 

Sequencing Consumables Market Trends

The increasing demand for personalized medicine has significantly contributed to the growth of the sequencing consumables industry. Personalized medicine, also known as precision medicine, involves tailoring medical treatments to the individual characteristics of each patient, including their genetic makeup.
 

• Personalized medicine relies on obtaining comprehensive genomic information from patients. This includes identifying genetic variations, mutations, and other genomic markers that may influence disease susceptibility, progression, or response to specific treatments.
   
• Sequencing consumables play a pivotal role in extracting, preparing, and processing DNA or RNA samples for sequencing, enabling the generation of the genomic data required for personalized treatment decisions.
   
• In oncology, precision medicine is particularly prominent. Cancer genomics involves analyzing the genetic alterations in a patient's tumor to identify specific mutations that may be targeted by personized treatment. Such benefits through target therapies will further stimulate the market growth.
   

Sequencing Consumables Market Analysis

Based on product type, the market is segmented into kits, reagents, accessories. The kits segment is poised for significant growth at a CAGR of 22.4% during the forecast period. Moreover, the kit segment is further bifurcated into DNA library preparation, RNA library preparation, purification & quality control, library quantification, target enrichment, and other kit types.
 

• With the increasing interest in single-cell omics, there has been a rise in the availability of single-cell sequencing kits. These kits are designed to support the isolation, preparation, and sequencing of individual cells, enabling researchers to explore cellular heterogeneity and uncover insights not possible with bulk sequencing.
   
• As laboratories seek to increase throughput and efficiency, there is a trend toward sequencing kits that are compatible with automated liquid handling systems. Automation can streamline workflows, reduce manual errors, and enhance reproducibility. Thus, such aforementioned factors will drive the market expansion.
   

Based on platform, the market is segmented into 1^st, 2^nd, and 3^rd generation. The 2^nd generation segment accounted for a revenue share of 80.4% in 2023 and is estimated to follow similar trend over the coming years.
 

• NGS technologies, including Illumina sequencing, have been the primary drivers of the sequencing consumables market for over a decade. Illumina sequencing platforms are known for their high throughput, allowing researchers to generate large amounts of sequencing data in a relatively short time.
   
• The cost-effectiveness of Illumina sequencing has made it widely accessible to researchers, enabling a broad range of applications from small-scale projects to large-scale genomics initiatives.
   
• It has been widely adopted across various research domains, including spatial genomics and transcriptomics, epigenomics, and metagenomics. The versatility of Illumina platforms has contributed to their popularity among researchers conducting diverse experiments and studies.

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the sequencing consumables market is segmented into clinical diagnostics, forensic diagnostics, pharmacogenomics, agrigenomics and other applications. The clinical diagnostics segment is further divided into cancer diagnostics, infectious disease diagnostics, reproductive health, and other clinical applications. The clinical diagnostics segment is poised for significant growth at a CAGR of 23% during the forecast period.
 

• Cancer genomics has emerged as a major application within clinical diagnostics. Sequencing technologies are employed to analyze the genomic alterations in tumors, facilitating the identification of targeted therapies.
   
• Molecular diagnostics based on genomics play a crucial role in cancer diagnosis, prognosis, and treatment selection.
   
• Furthermore, sequencing technologies are employed in the detection and characterization of infectious agents, contributing to the diagnosis and monitoring of infectious diseases. NGS is utilized for pathogen identification, antimicrobial resistance profiling, and epidemiological studies.
   

The market by end-use is categorized into pharmaceutical and biotechnology companies, hospitals and laboratories, academic research institutes, and other end-users. The academic research institutes segment accounted for around USD 3.1 billion revenue size in 2023.
 

• Academic research institutes play a crucial role in advancing genomic research and developing new sequencing methodologies. They contribute to basic research, innovation, and the training of future scientists. Genomic studies across various disciplines, including genetics, molecular biology, evolutionary biology, and environmental genomics.
   
• A broad range of sequencing consumables to support diverse research projects, from fundamental genomics studies to specialized applications such as single-cell sequencing.
   
• Genetics is a core focus of academic genomics research. Institutes explore heredity, gene expression, and the inheritance of traits, contributing to the understanding of how genes influence biological processes and contribute to genetic disorders.
   
• Their contributions not only advance the understanding of genetics and molecular biology but also have broader implications for medicine, agriculture, ecology, and beyond.

North America market accounted for USD 3.2 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• Companies in North America involved in sequencing consumables have engaged in strategic partnerships and collaborations to expand their product offerings and market presence.
   
• Government initiatives supporting genomics research and precision medicine have contributed to the growth of the sequencing consumables market.
   
• Funding for large-scale genomics projects and initiatives focused on genomic data collection has increased the demand for consumables.
   
• Next generation sequencing technologies, including platforms from companies such as Illumina, have experienced rapid adoption in North America. The demand for consumables compatible with NGS platforms has grown as these technologies become more prevalent in research, clinical diagnostics, and various applications.
   

Sequencing Consumables Market Share

The sequencing consumables industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Illumina, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation among others have a notable presence in the market.
 

Sequencing Consumables Market Companies

Some of the eminent market participants operating in the sequencing consumables industry include:

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F Hoffmann-La Roche Ltd.
• Illumina, Inc.
• New England Biolabs
• PerkinElmer, Inc.
• Qiagen N.V.
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
   

Sequencing Consumables Industry News

• In November 2023, Illumina Inc. had unveiled the Global Health Access Initiative, a program designed to facilitate access to sequencing tools for public health initiatives in low- and middle-income countries (LMICs). Developed in collaboration with funders, customers, and market facilitators, including the nonprofit ‘FIND’, the initiative was set to offer reduced pricing structures on selectable sequencing products from Illumina. Additionally, it aimed to tackle significant international logistics and supply chain challenges to enhance the effectiveness of public health efforts in LMICs.
   
• In May 2023, Pfizer and Thermo Fisher Scientific had jointly revealed a collaboration agreement aimed at expanding local access to next-generation sequencing (NGS)-based testing for patients with lung and breast cancer. This collaborative effort was intended to extend its reach to more than 30 countries, with a particular focus on regions such as Latin America, Africa, the Middle East, and Asia. The initiative strategically addressed areas where advanced genomic testing had been historically restricted or unavailable, aimed to enhance diagnostic capabilities for lung and breast cancer patients in these underserved regions.
   

Sequencing consumables market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Kits
  • DNA library preparation
  • RNA library preparation
  • Purification & quality control
  • Library quantification
  • Target enrichment
  • Other kit types 
• Reagents      
• Accessories

Market, By Platform

• 1^st generation sequencing consumables
• 2^nd generation sequencing consumables
• 3^rd generation sequencing consumables
   

Market, By Application

• Clinical
  • Cancer diagnostics
  • Infectious disease diagnostics
  • Reproductive health
  • Other clinical applications
• Forensic diagnostics
• Pharmacogenomics
• Agrigenomics
• Other applications

Market, By End-use

• Pharmaceutical and biotechnology companies
• Hospitals and laboratories
• Academic research institutes
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa